Letter: Pa. regulators must offer clear medical marijuana guidelines

·1 min read

Regulators must offer clear medical marijuana guidelines for workers

Since 2016, Pennsylvania’s medical marijuana program has provided more than 600,000 patients and caregivers with lifesaving medicine. Each day Pennsylvania’s medical marijuana patients responsibly use their medicine to treat one of 23 serious medical conditions. Unfortunately, many patients fear that their employment could be affected given the failure of regulators to explain and enforce current law.

Shown here on Sept. 21, 2018 is a container of dry-leaf marijuana flower produced by Standard Farms and purchased from the Rise Erie medical marijuana dispensary in Erie, Pennsylvania.
Shown here on Sept. 21, 2018 is a container of dry-leaf marijuana flower produced by Standard Farms and purchased from the Rise Erie medical marijuana dispensary in Erie, Pennsylvania.

The commonwealth’s regulators have failed the Pennsylvania workforce by remaining silent when it comes to employment matters. Now big employers are lobbying for SB 749, legislation that will punish working patients for accessing lifesaving medicine. At a time when employers are struggling to hire, it is unimaginable that Pennsylvania would even consider legislation to further restrict the workforce.

Instead of “opening” a complex, bipartisan piece of legislation, our representatives should call on the Pennsylvania secretary of health and secretary of labor to issue clear guidance for existing law. Guidance would provide clarity and certainty for all parties.

If you or someone you love is a Pennsylvania medical marijuana patient, please call your senator and tell them to oppose SB 749.

Meredith Buettner, executive director of Pennsylvania Cannabis Coalition

This article originally appeared on Erie Times-News: Letter: Pa. regulators must offer clear medical marijuana guidelines

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting